Friday, June 23, 2017 6:28:31 AM
At present, only the clinical test version will be available, the commercial version will be launched in the first half of 2018, to encourage Asian users to self-test, the cost will be lower than the mammography.
The company has now started to develop its Asian business through the Hong Kong Science and Technology Parks Corporation. It aims to obtain the certification of the State Administration of Food and Drug Administration (MSW) of China to further promote the detection of breast cancer.
Cancer is the number one killer of people of Hong Kong
ITBra is simple to use, there are 15 sizes
人工智能 iTBra 隨時隨地無痛驗乳癌 - https://t.co/fpTI4myzvC pic.twitter.com/SUWXXPwVFL
— unwire.hk (@UnwireLife) June 23, 2017
https://unwire.hk/2017/06/23/cyrcadia-it-bra/life-tech/
Disclaimer: This information is only my opinion and should not be considered as an advice or a recommendation to investors or potential investors in relation to holding, purchasing or selling securities or other financial products or instruments.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
